Servatus Biopharmaceuticals Ltd

Servatus Biopharmaceuticals Ltd Servatus Ltd is an Australian biotech company creating safe and effective microbiome therapies

22/08/2023
A great story from Jessica Ross at the ABC News (Australian Broadcasting Corporation) sharing the exciting news that our...
28/06/2023

A great story from Jessica Ross at the ABC News (Australian Broadcasting Corporation) sharing the exciting news that our live biotherapeutic treatment for insomnia has shown promising results in the first stage of its Phase 1/2 human clinical trials.

Jessica talked to Servatus Ltd CEO Dr Wayne Finlayson about the trial so far, and the potential of live biotherapeutics to treat insomnia and other conditions.

The trial, which is being conducted by Dr Deanne Curtin at the Sleep Disorders Centre at The Prince Charles Hospital in Brisbane, is set to expand to further verify the results seen so far.

More than half the country experiences disrupted sleep, but an Australian-first clinical trial of a bacteria-based treatment for insomnia is delivered "very promising" results.

Today marks  , which recognises the importance of microbes in the health of all of us. At Servatus Biopharmaceuticals Lt...
27/06/2023

Today marks , which recognises the importance of microbes in the health of all of us.

At Servatus Biopharmaceuticals Ltd, the microbiome is central to the work we’re doing to develop live biotherapeutic treatments, including for Irritable Bowel Syndrome with constipation (IBSc), insomnia, rheumatoid arthritis, and other diseases and conditions.

We are excited to share that Phase I clinical trials our live biotherapeutic treatment for Irritable Bowel Syndrome with...
22/05/2023

We are excited to share that Phase I clinical trials our live biotherapeutic treatment for Irritable Bowel Syndrome with constipation (IBSc) have shown extremely encouraging results.

Servatus partnered with leading Gerald Holtmann at Princess Alexandra Hospital, Brisbane to conduct the trial, with results validating both safety and clinically meaningful improvements by reducing constipation symptoms in 48% of participants and improving quality of life in 62% of participants.

Learn more here: https://servatus.com.au/news/

We are pleased to announce that our Head of Clinical Research, Dr Samantha Coulson and Research Scientist Dr Renato Lemg...
11/05/2023

We are pleased to announce that our Head of Clinical Research, Dr Samantha Coulson and Research Scientist Dr Renato Lemgruber are presenting at next week’s Microbiome Connect: Asia conference in Seoul, South Korea.

Dr Coulson and Dr Lemgruber will be speaking on key and topics.

Microbiome Connect: Asia is a forum dedicated to accelerating pipeline development in the region by showcasing updates from leading companies, addressing regional regulatory issues, and promoting collaboration between industry, academia, and service providers.

Follow the link to learn more: https://www.microbiomeconnectasia.com/events/microbiome-connect-asia-2023.

Another great story about our rheumatoid arthritis clinical trial was recently featured on ABC TV + iview across the cou...
22/03/2023

Another great story about our rheumatoid arthritis clinical trial was recently featured on ABC TV + iview across the country.

The story includes interviews with Servatus CEO Dr Wayne Finlayson and principal investigator Professor Peter Nash, who both discuss the world-first based clinical trial.

In a world first trial, Queensland scientists investigate whether introducing live, beneficial bacteria to the gut could treat or even cure rheumatoid arthri...

New Rheumatoid arthritis (RA) Clinical TrialWho can take part in this study?In order to be eligible to participate in th...
24/01/2023

New Rheumatoid arthritis (RA) Clinical Trial

Who can take part in this study?

In order to be eligible to participate in the study, you must meet all of the following:
● You are aged 18 - 80 years old
● You have been diagnosed with Rheumatoid arthritis

Who is unable to take part in this study?

Unfortunately, if you meet any of the following, this study is not the right fit for you:
● Anyone who has a history of any other rheumatic autoimmune disease, other than Sjogren’s syndrome

How long will the study take?

If you agree to take part, and the study is suitable for you, your participation in the study is expected to last up to 16 weeks. This includes:
● 12 week treatment period
● 4 week follow-up period
● 5 study visits and 1 phone call

To register: https://www.surveymonkey.com/r/RheumatoidArthritisTrial

What is Rheumatoid arthritis?Rheumatoid arthritis (RA) is an autoimmune disease that causes pain and swelling of the joi...
24/01/2023

What is Rheumatoid arthritis?

Rheumatoid arthritis (RA) is an autoimmune disease that causes pain and swelling of the joints. The normal role of your body’s immune system is to fight off infections to keep you healthy. Autoimmune diseases cause your immune system to attack your own healthy tissues.

During RA, the immune system targets the lining of the joints, causing inflammation and joint damage. RA usually affects the smaller joints, such as the joints in the hands and feet. However larger joints such as the hips and knees can also be affected.

CEO Dr Wayne Finlayson was interviewed on Proactive this week to discuss the start of our Phase I/II human clinical tria...
12/01/2023

CEO Dr Wayne Finlayson was interviewed on Proactive this week to discuss the start of our Phase I/II human clinical trial, which is studying the effects of using live to treat the debilitating condition of rheumatoid (RA).

You can watch the interview here:
https://lnkd.in/gp28WiEm

Servatus Biopharmaceuticals Ltd director and CEO Wayne Finlayson gives Andrew Scott from Proactive a brief recap on the company which has two platforms, Engi...

📢 We are investigating a potential new treatment for Rheumatoid arthritis (RA)If you have RA, we are inviting you to tak...
11/01/2023

📢 We are investigating a potential new treatment for Rheumatoid arthritis (RA)

If you have RA, we are inviting you to take part in our latest medical study investigating a potential bacterial treatment!

https://myclinicalstudy.com.au/raclinicalstudy

Address

Lomandra Place
Coolum Beach, QLD
4573

Alerts

Be the first to know and let us send you an email when Servatus Biopharmaceuticals Ltd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Servatus Biopharmaceuticals Ltd:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram